LATEST NEWS
NeuroDelta presents at EPIC Biotechnology Conference... More here

Company

NeuroDelta is a private company, headquartered in London, UK.

The company is focussed on developing novel therapeutic treatments and diagnostics relating to the treatment of Alzheimer's Disease.

NeuroDelta is based on research carried out by Dr Nathanil Milton at The Royal Free Hospital Medical School while funded by a private company that retained the resulting intellectual property.

The intellectual property and other know-how was injected into a new company, NeuroDelta, which has developed the initial work further and continues to do so with research being carried out in London, UK, and Mainz, Germany.